Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Opioid Makers Paid Millions to Advocacy Groups

Nate Raymond  |  

References

  1. U.S. Senate Homeland Security & Governmental Affairs Committee, Ranking Member’s Office. Senate report: Fueling an epidemic: Exposing the financial ties between opioid manufacturers and third party advocacy groups. Scribd. 2018 Feb 13.
  2. U.S. Sen. Claire McCaskill’s Office. News release: Millions in payments among findings of McCaskill opioid investigation into ties between manufacturers and third party advocacy groups. 2018 Feb 12.

Related Articles

    U.S. Senator Reveals Results of Opioid Inquiry into Insys

    BOSTON (Reuters)—Insys Therapeutics Inc sought to manipulate insurance payment approval for an opioid cancer pain drug called Subsys even if for inappropriate uses, according to a U.S. Senate report on the opioid crisis released on Wednesday. The report, released by Democratic Senator Claire McCaskill, said those efforts led to an Insys employee making misleading statements…

    ah_designs / shutterstock.com

    The Perils of Pain Meds Revisited

    More than 10 years ago, I wrote a commentary in The Rheumatologist, called “Perils of Pain Meds,” about the over-prescribing of opioid analgesics for common causes of chronic noncancer pain, which was a major contributor to the opioid epidemic.1 Since that time, although there has been a greater than 20% decrease in opioid prescribing, the…

    The Benefits of Blood Money: OxyContin & Ethics

    On Feb. 9, 2019, protesters gathered at the Guggenheim Museum in New York City to lead a march down Fifth Avenue to the Metropolitan Museum of Art.1 As a general rule, news from the world of art is not a topic discussed in these pages, but if you indulge me for just a little bit…

    New Jersey Sues Insys as Opioid Maker Settles with Massachusetts

    BOSTON (Reuters)—New Jersey on Thursday accused Insys Therapeutics Inc of engaging in a fraudulent scheme to boost sales of a fentanyl-based cancer pain drug, as Massachusetts announced a $500,000 settlement with the drugmaker to resolve similar allegations. The lawsuit by New Jersey Attorney General Christopher Porrino accused Insys of illegally directing its sales force to…